therapeutics target indications discovery non-clinical clinical
Small molecules CR-E1 Autoimmune disease* on on  
B-cell lymphoma on    
Gene therapy CR-P1 NASH on on  
HCC on    
Therapeutic proteins CR-T1~T4 Autoimmune disease* on on  
CR-T5~T8 NASH on    

* Our autoimmune disease treatment candidates are being developed as indications for psoriasis, psoriatic arthritis, rheumatoid arthritis and/or inflammatory bowel disease. Indications will be extended to ankylosing spondylitis and graft-versus-host disease on medical and experimental basis.